<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Apo T BV — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/apo-t-bv</link>
    <description>Plain-English explanations of patents assigned to Apo T BV, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Sun, 12 Jul 2026 09:25:21 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/apo-t-bv/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Targeting Bad Cells with Toxic Antibodies for Cancer and Autoimmune Disease</title>
      <link>https://patentbrief.org/patent/us/20210205465/aberrant-cell-restricted-immunoglobulins-provided-with-a-toxic-moiety</link>
      <description>This patent describes special antibodies equipped with a toxic payload that specifically seek out and bind to unique markers on diseased cells, like cancer or autoimmune cells, to destroy them.</description>
      <pubDate>Sat, 04 Jul 2026 10:57:44 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/20210205465/aberrant-cell-restricted-immunoglobulins-provided-with-a-toxic-moiety</guid>
    </item>
  </channel>
</rss>
